US FDA approves Vera's kidney disease drug

By Siddhi Mahatole and Puyaan Singh July 7 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved ...

US FDA officials say hiring picks up speed with more than 2,000 jobs to start

By Deena Beasley June 24 (Reuters) - The U.S. Food and Drug Administration, which cut more than 3,000 employees last year, ...

US FDA updates guidance to speed up drug development

June 22 (Reuters) - The U.S. Food and Drug Administration said on Monday it is launching a series of measures to speed up ...

US FDA approves Vertex's gene therapy for sickle cell disease in children as young as two

July 1 (Reuters) - The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' gene therapy in ...

US FDA declines to approve Unicycive's kidney disease drug

By Padmanabhan Ananthan June 30 (Reuters) - Unicycive Therapeutics said on Tuesday the U.S. drug regulator has declined to ...

From caffeine to 'healthy' labeling, FDA sets year-end agenda for US food supply

The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year's end.
C&EN

FDA launches multipronged attack on flu vaccines

The US Food & Drug Administration refused to review Moderna’s mRNA flu vaccine this week. Regulators had already shaken up the industry by requiring new safety warnings and don’t appear to be on track ...
CNN

FDA moves to fast-track review of psilocybin and methylone for mental health

Some psychedelic drugs, once considered fringe, are getting a step closer to possibly being approved for use as mental health treatments in the United States. The US Food and Drug Administration on ...

FDA approves new sunscreen ingredient used for years in Europe and Asia

A new sunscreen ingredient used for years in Europe and Asia was approved for use in the US. The ingredient is safer than some currently in use, experts say.
RAPS

FDA warns drugmakers in US, Japan, and India for GMP issues

The US Food and Drug Administration (FDA) recently issued warning letters to drugmakers in Japan and the US, as well as a producer of active pharmaceutical ingredients (APIs) based in India, citing ...